Cita APA (7a ed.)

J, S., WJ, C., A, W., & M, G. (2020). Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Dove Medical Press.

Cita Chicago Style (17a ed.)

J, Szarmach, Cubała WJ, Włodarczyk A, y Gałuszko-Węgielnik M. Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Dove Medical Press, 2020.

Cita MLA (8a ed.)

J, Szarmach, et al. Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Dove Medical Press, 2020.